Article Text

Download PDFPDF
First independent replication study confirms the strong genetic association of ANXA11 with sarcoidosis
  1. Yun Li1,2,
  2. Stefan Pabst3,
  3. Christian Kubisch1,2,4,
  4. Christian Grohé3,5,
  5. Bernd Wollnik1,2,4
  1. 1Center for Molecular Medicine Cologne (CMMC), Germany
  2. 2Institute of Human Genetics, Germany
  3. 3Medizinische Klinik II, Rheinische-Friedrich-Wilhelms Universität Bonn, Germany
  4. 4Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Germany
  5. 5Pneumologische Klinik, Evangelische Lungenklinik, Berlin, Germany
  1. Correspondence to Bernd Wollnik, Center for Molecular Medicine Cologne (CMMC), Institute of Human Genetics, Kerpener Str. 34, 50931 Cologne, Germany; bwollnik{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Sarcoidosis is an inflammatory disease characterised by the presence of granulomas that can affect the skin, lungs, heart, brain and nervous system, eyes and various other tissues and organs.1 The disease can present in an acute or subacute form and is often self-limiting, but in many cases it is chronic with variable disease activity over many years.2 A genetic association between sarcoidosis and a truncating splice-site mutation in the gene BTNL2 (butyrophilin-like 2, a member of the immunoglobulin gene family) has been confirmed in different studies and populations.3–5

Very recently the first whole-genome association study (WGAS) reported a strong association …

View Full Text


  • Funding BONFOR (University of Bonn).

  • Competing interests None.

  • Ethics approval This study was conducted with the approval of the University of Bonn 060/05.

  • Provenance and peer review Not commissioned; not externally peer reviewed.